SafetyVigilance™ notification system enables sponsors to optimize the management of pharmacovigilance notifications and meet regulatory requirements

Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsize, full-service contract research organization (CRO), today announced its new SafetyVigilance™ online pharmacovigilance notification portal, hosted by InvestigatorSpace™, which drives increased speed, accuracy, and efficiency in the global distribution of safety event communications. The portal complements the organization’s already comprehensive suite of pharmacovigilance capabilities, which include a pharmacovigilance regulatory intelligence database that is unique to Worldwide.

“Worldwide has the global reach many other midsize CROs don’t have, and this enables us to complete global safety submissions because of the unique local regulatory requirements necessary. We have the support on the ground. The customers we work with depend on Worldwide to maintain the highest safety standards, no matter how challenging it may be,” said Peter Benton, President and Co-CEO, Worldwide Clinical Trials.

SafetyVigilance™ improves process improvement and management of patient safety data related to sponsor products, alleviating workflow obstacles. It also reduces administrative burdens on sponsors by driving increased speed and accuracy in distributing safety events, mitigating over-distribution and duplication of notifications, streamlining reporting, and centralizing receipt and acknowledgement of all events.

Worldwide Clinical Trials’ full-scope pharmacovigilance services team has more than 20 years' experience in adverse event case processing, global regulatory submissions, development safety update reports, functional service provider services, risk management, global safety database resources, and auxiliary support services. To learn more, visit https://www.worldwide.com/news-views/pharmacovigilance-cro-services-patient-safety-sponsor-security/.

About Worldwide Clinical Trials

Worldwide Clinical Trials is a global, midsize contract research organization (CRO) that provides top-performing preclinical and Phase I-IV clinical development services to the biotechnology and pharmaceutical industries.

Founded in 1986 by physicians committed to advancing medical science, our full-service clinical experience ranges from early phase and bioanalytical sciences through late phase studies, post approval, and real-world evidence. Major therapeutic areas of focus include cardiovascular, metabolic, neuroscience, oncology, and rare diseases. With infrastructure spanning 60 countries and offices in North and South America, Eastern and Western Europe, Russia and Asia, Worldwide is powered by its more than 2,600 employee experts. We are the cure for the common CRO.

For more information, please visit www.worldwide.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005468/en/